Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Capital Expenditures (2023 - 2025)

BrightSpring Health Services (BTSG) has disclosed Capital Expenditures for 3 consecutive years, with -$51.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures fell 697.59% year-over-year to -$51.1 million, compared with a TTM value of $6.8 million through Dec 2025, down 44.24%, and an annual FY2025 reading of $6.8 million, down 44.24% over the prior year.
  • Capital Expenditures was -$51.1 million for Q4 2025 at BrightSpring Health Services, down from $53.7 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $53.7 million in Q3 2025 and bottomed at -$51.1 million in Q4 2025.
  • Average Capital Expenditures over 3 years is $7.7 million, with a median of $13.6 million recorded in 2023.
  • Peak annual rise in Capital Expenditures hit 3169.39% in 2025, while the deepest fall reached 697.59% in 2025.
  • Year by year, Capital Expenditures stood at $16.8 million in 2023, then plummeted by 49.25% to $8.5 million in 2024, then plummeted by 697.59% to -$51.1 million in 2025.
  • Business Quant data shows Capital Expenditures for BTSG at -$51.1 million in Q4 2025, $53.7 million in Q3 2025, and -$6.3 million in Q2 2025.